TRIMAS CORP Q4 FY2024 earnings call

Management Statement and Operational Highlights

• Business Line Trends: Positive trends in Q4 across all business lines; actions taken to improve customer engagement and conversion rates.
• Packaging Segment: Achieved 10% organic growth in Q4, driven by dispensing products in beauty/personal care. Invested in assembly lines, injection molding, and tooling; seeing OEE improvements.
• Aerospace Segment: Invested in OEE improvements, benefiting from recovering aerospace market. Segment EBITDA rates improved vs prior year; strong order book entering 2025.
• Specialty Products: Sold aero engine business; North Cylinder at bottom of destocking trough, with cost restructuring taken.
• Acquisitions/Divestitures: Completed acquisition of GMT Aerospace (€22M annualized sales, ~50% to Airbus); sold aero engine business.
• 2025 Outlook: Strong balance sheet, low leverage; focus on portfolio shift to unlock value, with TriMas Packaging and Aerospace as key growth platforms.

Segment Performance

• TriMas Packaging: Largest segment at 55% of total sales. Fourth quarter net sales were $123 million vs $114 million prior year, an increase of 8.4%. Organic sales increased almost 10%. In 2025, expected year-over-year sales growth to return closer to a GDP plus rate (2%-4%), with margin enhancement due to higher sales rates and improved manufacturing efficiencies. Exposed to US tariff increases, especially from China.
• TriMas Aerospace Group: Represents 32% of total sales. Q4 net sales increased by more than $14 million (+22%) driven by commercial aircraft production rates, strategic actions, and improved yields. Ended 2024 with a record backlog >$350M. 2025 expected low double-digit organic sales growth, with margin enhancement from backlog and strategic pricing.
• Specialty Products Segment: Represents 13% of total sales. North Cylinder sales down 6.5% Q4. 2025 anticipates flat to slightly increasing sales in first half, mid-single-digit growth full year, with margin enhancement from completed cost reductions.

Guidance

• Full year consolidated sales growth 4%-6% (includes GMT Aerospace acquisition). Adjusted EPS $1.70-$1.85 (midpoint +7% vs prior year). Adjusted EBITDA $150M-$165M (+7% y/y), with second half North Cylinder recovery and GMT acquisition offsetting divestiture impact.
• Packaging: 2025 sales growth 2%-4% (reversion from 2024 strong growth), margin enhancement from higher sales and efficiencies.
• Aerospace: 2025 low double-digit organic sales growth, margin enhancement from backlog and pricing.
• North Cylinder: 2025 mid-single-digit sales growth, margin enhancement from cost reductions.

Risks

• Exposure to US tariff increases, particularly from China; uncertainty around timing and size of future tariff changes, with active contingency planning in place.

Question and Answer

Q: Ken Newman asked about margin enhancement quantification across businesses, tariffs impact on Packaging.

A: Scott Mell said Packaging margin enhancement ~100-150bps, Aerospace ~150-200bps, North Cylinder ~100-150bps. Tariffs: near-term mitigation via commercial actions, long-term via manufacturing relocation.

Q: Ken Newman asked about CEO transition and portfolio preference.

A: Thomas Amato said board working on CEO transition, board assessing value unlock; TriMas Packaging and Aerospace are high-value platforms, North Cylinder will improve as market recovers.

Q: Hamed Khorsand asked about Packaging execution and margin impact of cost actions.

A: Scott Mell said Packaging Q4 headwinds abated, 2025 margin enhancement 100-150bps; Thomas Amato added cost actions help margins and secure growth.